Table 4. Patient-reported outcomes for the sample as a whole and for the eosinophilic phenotype.
Variable | Total | Blood eosinophil count > 300 cells/mm3 | Blood eosinophil count of ≤ 300 cells/mm3 | p |
---|---|---|---|---|
(N = 385) | (n = 154) | (n = 231) | ||
SGRQ | ||||
Symptoms score (%) | ||||
Median (IQR) | 55.6 (39.3-71.9) | 54.3 (40.2-75.2) | 57.6 (38.2-70.1) | 0.4658* |
Activity score (%) | ||||
Median (IQR) | 60.8 (49.2-74.6) | 60.4 (47.7-73.6) | 61.1 (53.2-79.2) | 0.2691* |
Impact score (%) | ||||
Median (IQR) | 39.9 (23.3-55.6) | 38.8 (21.6-54.0) | 42.2 (24.2-58.3) | 0.1320* |
Total score (%) | ||||
Median (IQR) | 49.8 (35.3-63.1) | 48.8 (34.6-61.0) | 50.4 (35.8-65.4) | 0.2405† |
ACQ-5 | ||||
Total score | ||||
Median (IQR) | 2.0 (1.0-2.8) | 1.8 (1.0-2.8) | 2.2 (1.0-3.0) | 0.3290* |
ACQ-5 categories, n (%) | ||||
Well-controlled | 141 (36.6) | 59 (38.3) | 82 (35.5) | 0.5745†† |
Uncontrolled | 244 (63.4) | 95 (61.7) | 149 (64.5) |
SGRQ: Saint George’s Respiratory Questionnaire; and ACQ-5: 5-item Asthma Control Questionnaire. *Mann-Whitney test. †Student’s t-test. ††Chi-square test.